| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 04/02/2002 | US6365622 Antioxidant composition comprising acetyl L-carnitine and α-lipoic acid |
| 04/02/2002 | US6365579 Nitrate esters and their use for neurological conditions |
| 04/02/2002 | US6365155 Monoclonal antibody, antibody fragment, mixture or derivative thereof, which binds to ancrod and inhibits its activity |
| 03/28/2002 | WO2002024923A1 Polypeptide having phospholipase a2 actiivty |
| 03/28/2002 | WO2002024715A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 03/28/2002 | WO2002024200A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 03/28/2002 | WO2001085182A3 Combined cartilage and plant extract compositions |
| 03/28/2002 | WO2001085169A3 R-eliprodil for treating glaucoma |
| 03/28/2002 | WO2001085152A3 R-eliprodil for treating glaucoma |
| 03/28/2002 | WO2001072327A3 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies |
| 03/28/2002 | WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 03/28/2002 | WO2001064204A3 Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | CA2423156A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor |
| 03/28/2002 | CA2423058A1 Polypeptide having phospholipase a2 activity |
| 03/27/2002 | EP1190721A2 A method for the anhydrous loading of nicotine onto ion exchange resins |
| 03/27/2002 | EP1190072A2 22012, a novel human carboxypeptidase |
| 03/27/2002 | EP1189604A2 Zinc ionophores as anti-apoptotic agents |
| 03/27/2002 | EP1009418B1 Robinia pseudoacacia lectin and its uses |
| 03/27/2002 | EP0934062B1 Antioxidant activity of 3-dehydroshikimates |
| 03/27/2002 | CN1342079A Treatment and prevention of reactive oxygen metablite-mediated cellular damage |
| 03/27/2002 | CN1342073A Antioxidant compositions and methods for companion animals |
| 03/27/2002 | CN1341588A Intermediate product for preparing substituted 2,4-thiazolidine diketone derivative |
| 03/27/2002 | CN1341423A Capsule for resisting fatigue |
| 03/26/2002 | US6362236 Statin compound |
| 03/21/2002 | WO2002022851A2 Novel tumor-associated marker |
| 03/21/2002 | WO2002022677A2 Variants of allergenic proteins of the group 2 of dermatophagoides |
| 03/21/2002 | WO2002022611A2 Caspase inhibitors and uses thereof |
| 03/21/2002 | WO2002022573A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | WO2002022142A1 Cough depressant composition containing iron for angiotensin-converting enzyme inhibitor inducing cough |
| 03/21/2002 | WO2002022135A1 Creatine ester pronutrient compounds and formulations |
| 03/21/2002 | WO2002022134A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 03/21/2002 | WO2002022112A2 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/21/2002 | WO2001078529A3 Compositions and methods for improving vascular health |
| 03/21/2002 | WO2001064165A3 Il-8 receptor antagonists |
| 03/21/2002 | WO2001035943A3 Dextrose and insulin fluid formulation for intravenous infusion |
| 03/21/2002 | US20020035139 COX-2 inhibitors and the prevention of the side effects of radiation therapy |
| 03/21/2002 | US20020035093 Methods for the administration of amifostine and related compounds |
| 03/21/2002 | DE10044905A1 (2-Azabicyclo[2.2.1]hept-7-yl)methanol-Derivate als nikontinische Acetylcholinrezeptor Agonisten (2-azabicyclo [2.2.1] hept-7-yl) methanol derivatives as nikontinische acetylcholine receptor agonists |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2421920A1 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 03/21/2002 | CA2418720A1 Caspase inhibitors and uses thereof |
| 03/20/2002 | EP1188438A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| 03/20/2002 | EP1187854A1 Per(3,6-anhydro)cyclodextrin derivatives, preparation and use thereof for separating ions |
| 03/20/2002 | EP1187637A2 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 03/20/2002 | EP0840770A4 Process for extraction of proanthocyanidins from botanical material |
| 03/20/2002 | CN1341023A Agent for use in transplantation |
| 03/20/2002 | CN1081011C Health-care tonic canned food |
| 03/19/2002 | US6358946 C-6 ring-substituted pyrido[1,2-a]benzimidazole derivatives useful in treating central nervous system disorders |
| 03/19/2002 | US6358945 Compounds useful as anti-inflammatory agents |
| 03/19/2002 | US6358930 Treatment of C. difficile toxin B associated conditions |
| 03/19/2002 | US6358919 Polymer compounds comprising glycosphingosine |
| 03/19/2002 | US6358536 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 03/19/2002 | CA2179521C 2,4-disulphophenyl butylnitrone, its salts and their use as pharmaceuti cal spintraps |
| 03/15/2002 | CA2357155A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/14/2002 | WO2002020846A2 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure |
| 03/14/2002 | WO2002020742A1 Use of ip3 kinases for preparing medicines for treating oxidative stress-related diseases |
| 03/14/2002 | WO2002020112A1 Process for selectively extracting bioactive components |
| 03/14/2002 | WO2002019982A2 Cosmetic composition and method for reducing or preventing wrinkling |
| 03/14/2002 | WO2002019972A2 Stabilized ascorbic acid solutions |
| 03/14/2002 | WO2001070734A3 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 03/14/2002 | WO2000065028A9 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 03/14/2002 | CA2419983A1 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure |
| 03/13/2002 | EP1185862A2 Method and compositions relating to insulin resistance disorders |
| 03/13/2002 | EP1185700A1 49 human secreted proteins |
| 03/13/2002 | EP1185532A1 Peroxynitrite decomposition catalysts and methods of use thereof |
| 03/13/2002 | EP1185175A1 Method of increasing the content of flavonoids and phenolic substances in plants |
| 03/13/2002 | EP0859623B1 Absorbable prophylactic composition for protection against ionising or non-ionising electromagnetic waves |
| 03/13/2002 | CN1339297A New medicine release system-liposolubility medicinal preparation |
| 03/12/2002 | US6355666 Protected forms of pharmacologically active agents and uses therefor |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/12/2002 | US6355241 In vivo production and delivery of erythropoietin |
| 03/07/2002 | WO2002017965A1 Medicinal compositions |
| 03/07/2002 | WO2002017945A1 Efficient method for producing compositions enriched in anthocyanins |
| 03/07/2002 | WO2002017938A1 Use of extracts of the cassia alata plant |
| 03/07/2002 | WO2002017732A2 Efficient method for producing compositions enriched in anthocyanins |
| 03/07/2002 | WO2001070176A3 Use of 3,4-dihydroxy-mandelic acid for protecting against oxidative damage caused by ultra-violet light |
| 03/07/2002 | WO2001068033A3 Il-8 receptor antagonists |
| 03/07/2002 | WO2001058956A3 Antibodies that bind human interleukin-18 and methods of making and using |
| 03/07/2002 | WO2001034774A3 Method for protection of mammalian cells by means of over-expressed g-2/m cell cycle coupler |
| 03/07/2002 | US20020028802 Solvent extraction; plant extracts |
| 03/07/2002 | US20020028790 Use of agonists or antagonists of P2 purinoceptors for the prevention glutamate-evoked cytotoxicity |
| 03/07/2002 | US20020028227 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 03/07/2002 | DE10040933A1 Verwendung von beta-Mannosylglycerat (Firoin) und/oder Derivaten, insbesondere dem beta-Mannosylglyceramid (Firoin-A), in kosmetischen und dermatologischen Formulierungen Use of beta-mannosylglycerate (firoin) and / or derivatives, in particular the beta-mannosylglyceramide (firoin-A), in cosmetic and dermatological formulations |
| 03/06/2002 | EP1183376A1 Isoflavonoid methylation enzyme |
| 03/06/2002 | EP1183237A1 Novel antioxidants, preparation methods and uses |
| 03/06/2002 | CN1338923A Method for controlling liposome size |
| 03/06/2002 | CN1338280A Prescriptions of 12 moxibustion medicine (for beautifying face and hair and treating dermatopathy) |
| 02/28/2002 | WO2002016381A2 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | WO2002016359A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015867A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations |
| 02/28/2002 | WO2002015863A1 Dermatological composition |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001045661A3 Cosmetic and/or pharmaceutical preparations |
| 02/28/2002 | WO2001042462A3 Phospholipase a2 inhibitory peptides from python reticulatus |
| 02/28/2002 | US20020025350 Dietary supplements |